221 related articles for article (PubMed ID: 14661993)
1. Emerging biotherapies for inflammatory bowel disease.
Cuzzocrea S
Expert Opin Emerg Drugs; 2003 Nov; 8(2):339-47. PubMed ID: 14661993
[TBL] [Abstract][Full Text] [Related]
2. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments.
Catalan-Serra I; Brenna Ø
Hum Vaccin Immunother; 2018; 14(11):2597-2611. PubMed ID: 29624476
[TBL] [Abstract][Full Text] [Related]
4. Cytokine blockade in inflammatory bowel diseases.
Perrier C; Rutgeerts P
Immunotherapy; 2011 Nov; 3(11):1341-52. PubMed ID: 22053885
[TBL] [Abstract][Full Text] [Related]
5. An immunomodulation strategy targeted towards immunocompetent cells or cytokines in inflammatory bowel diseases (IBD).
Heresbach D; Sémana G; Gosselin M; Bretagne MG
Eur Cytokine Netw; 1999 Mar; 10(1):7-15. PubMed ID: 10210767
[TBL] [Abstract][Full Text] [Related]
6. The present status and the recent development of the treatment for inflammatory bowel diseases: desirable effect of extracorporeal immunomodulation.
Takazoe M; Tanaka T; Kondo K; Ichimori T; Shinoda T
Ther Apher; 2002 Aug; 6(4):305-11. PubMed ID: 12164801
[TBL] [Abstract][Full Text] [Related]
7. Novel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion molecules.
Nakamura K; Honda K; Mizutani T; Akiho H; Harada N
World J Gastroenterol; 2006 Aug; 12(29):4628-35. PubMed ID: 16937430
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
9. Innate lymphoid cells in inflammatory bowel diseases.
Peters CP; Mjösberg JM; Bernink JH; Spits H
Immunol Lett; 2016 Apr; 172():124-31. PubMed ID: 26470815
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic J; Segal I
Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
[TBL] [Abstract][Full Text] [Related]
11. Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?
van Hogezand RA; Verspaget HW
Neth J Med; 1996 Feb; 48(2):64-7. PubMed ID: 8819802
[TBL] [Abstract][Full Text] [Related]
12. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
13. Immune dysfunction in inflammatory bowel disease.
Neuman MG
Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
[TBL] [Abstract][Full Text] [Related]
14. Experimental immunomodulatory therapy of inflammatory bowel disease.
Schreiber S
Neth J Med; 1998 Dec; 53(6):S24-31. PubMed ID: 9883011
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker.
Danese S
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S225-8. PubMed ID: 18598993
[TBL] [Abstract][Full Text] [Related]
16. New drug therapies on the horizon for IBD.
Perrier C; Rutgeerts P
Dig Dis; 2012; 30 Suppl 1():100-5. PubMed ID: 23075877
[TBL] [Abstract][Full Text] [Related]
17. Role of cytokines in the pathogenesis of inflammatory bowel disease.
Papadakis KA; Targan SR
Annu Rev Med; 2000; 51():289-98. PubMed ID: 10774465
[TBL] [Abstract][Full Text] [Related]
18. Biologic targeting in the treatment of inflammatory bowel diseases.
Bosani M; Ardizzone S; Porro GB
Biologics; 2009; 3():77-97. PubMed ID: 19707398
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseases.
Kanai T; Watanabe M
Expert Opin Biol Ther; 2005 Apr; 5(4):451-62. PubMed ID: 15934825
[TBL] [Abstract][Full Text] [Related]
20. Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.
Pouillon L; Bossuyt P; Peyrin-Biroulet L
Expert Opin Biol Ther; 2016 Oct; 16(10):1277-90. PubMed ID: 27329436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
